This clinical update serves as a brief summary of recently published and potentially practice changing journal articles. We review recent publications related to contraceptive safety and efficacy. The article discusses updated medical eligibility recommendations, effectiveness of progestin-only pills (including the newly approved over-the-counter pill), safety of estrogen containing contraceptives in those with migraine, topiramate interactions with hormonal contraception, and the use of nonsteroidal antiinflammatory drugs (NSAIDs) with oral emergency contraception to improve efficacy.
Get full access to this article
View all access options for this article.
References
1.
KottkeM, GoldthwaiteL, AroraK, et al.Patient-Centered Contraceptive Counseling. Obstetrics and Gynecology, 2022; 139(2):350–353; doi: 10.1097/AOG.0000000000004659
ZunigaC, BlanchardK, HarperCC, et al.Effectiveness and efficacy rates of progestin-only pills: A comprehensive literature review. Contraception, 2023; 119:109925; doi: 10.1016/j.contraception.2022.109925
4.
CalhounA, BaturP. Combined hormonal contraceptives and migraine: An update on the evidence. Cleveland Clinic Journal of Medicine, 2017; 84(8):631–638; doi: 10.3949/ccjm.84a.16033
5.
RosenfeldWE, DooseDR, WalkerSA, et al.Effect of topiramate on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in patients with epilepsy. Epilepsia, 1997; 38(3):317–323; doi: 10.1111/j.1528-1157.1997.tb01123.x
6.
DooseDR, WangS, PadmanabhanM, et al.Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia, 2003; 44(4):540–549; doi: 10.1046/j.1528-1157.2003.55602.x
7.
ClarkKE, MyattL. Prostaglandins and the reproductive cycle. Glowm, 2009; doi: 10.3843/GLOWM.10314
